Benefits and adverse effects of anti-emetic glucocorticoids in cancer.
Brüning
Ansgar
A
University Hospital Munich, Deptarment of Gynaecology and Obstetrics, Munich, Germany. ansgar.bruening@med.uni-muenden.de
Friese
Klaus
K
D000932:Antiemetics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000037:antagonists & inhibitors / Q000494:pharmacology; D002945:Cisplatin / Q000037:antagonists & inhibitors / Q000494:pharmacology; D003907:Dexamethasone / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology
D000932:Antiemetics; D000970:Antineoplastic Agents; D003907:Dexamethasone; D002945:Cisplatin